These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1317 related articles for article (PubMed ID: 23486264)

  • 1. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
    Robinson BM; Kennedy C; McLean J; McCaughan BC
    J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
    Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
    J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
    Osarogiagbon RU; Yu X
    J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
    Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
    World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
    Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
    Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
    Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
    World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidal reactions in regional lymph nodes of patients with early stage non-small cell lung cancer predict improved disease-free survival: a pilot case-control study.
    Steinfort DP; Tsui A; Grieve J; Hibbs ML; Anderson GP; Irving LB
    Hum Pathol; 2012 Mar; 43(3):333-8. PubMed ID: 21835432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.